RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Assessment of the intermuscular coherence for the early detection of diabetic peripheral neuropathy: a cross-sectional study
[EN] Diabetes mellitus (DM) is a global epidemic characterized by chronic hyperglycaemia due to insulin deficiency or resistance. Diabetic peripheral neuropathy (DPN) is one of its most common complications, affecting up to 50% of patients, and typically presents as a distal, symmetric, length-dependent neuropathy. Early detection of DPN is crucial to reduce its impact on quality of life and healthcare costs. Conventional diagnostic methods, such as nerve conduction studies, have important limitations, whereas surface electromyography (sEMG) offers a non-invasive, real-time assessment of neuromuscular function.
This study investigates the potential of sEMG, and specifically intermuscular coherence, as a sensitive biomarker for early DPN detection. Two coherence measures, partial coherence (PC) and partial directed coherence (PDC), derived from multivariate autoregressive (MVAR) models, were analysed in three groups: 33 healthy volunteers (CT), 10 diabetic patients with low DPN risk (LW), and 17 patients with moderate/high DPN risk (MH).
In early-stage DPN, synergistic muscle pairs showed increased PC and PDC values compared with controls, likely reflecting neuronal hyperexcitability and compensatory mechanisms within the nervous system. In contrast, more advanced DPN stages exhibited reduced coherence, consistent with nerve fibre loss and central nervous system (CNS) involvement, potentially exacerbated by structural CNS changes such as spinal cord atrophy, which may impair neural plasticity and adaptation.
Our results indicate that the dorsiflexor muscle pair, particularly the 10–50 Hz bandwidth of the PDC parameter, effectively discriminated between DPN stages, distinguishing all three groups with statistical significance. These findings support its potential as an early detection biomarker for DPN and as a tool for monitoring disease progression., This study was supported by grants from the Agencia Valenciana de la Innovacio (INNEST/2021/365) and the promoter POLISABIO (POLI-SABIO22_AP05) . Funding for the open-access publication charge was provided by CRUE-Universitat Politecnica de Valencia.